Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Authors:
- Jonathan D. HermanJHJonathan D. Herman
- Chuangqi WangCWChuangqi Wang
- John Stephen BurkeJBJohn Stephen Burke
- Yonatan ZurYZYonatan Zur
- Hacheming CompereHCHacheming Compere
- Jaewon KangJKJaewon Kang
- Ryan MacvicarRMRyan Macvicar
- Sabian TaylorSTSabian Taylor
- Sally ShinSSSally Shin
- Ian FrankIFIan Frank
- Don SiegelDSDon Siegel
- Pablo TebasPTPablo Tebas
Open Access
- 24 October 2022
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 3 (11)
Abstract
No abstract availableKeywords
Funding Information
- Sanofi Pasteur
- Musk Foundation
- National Institutes of Health (1U01CA260476-01, 3R37AI080289-11S1, 3UL1TR002556, CIVIC75N93019C00052, R01AI146785, T32 AI007061, U19AI135995-02, U19AI42790-01)
- Massachusetts Consortium on Pathogen Readiness
- Bill and Melinda Gates Foundation (INV-001650, OPP1146996)
- Massachusetts Institute of Technology
- Harvard University
This publication has 61 references indexed in Scilit:
- Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1Nature Medicine, 2012
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathwayNature, 2011
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samplesJournal of Immunological Methods, 2011
- Terminal sugars of Fc glycans influence antibody effector functions of IgGsCurrent Opinion in Immunology, 2008
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG FcScience, 2008
- The Impact of Glycosylation on the Biological Function and Structure of Human ImmunoglobulinsAnnual Review of Immunology, 2007
- Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc SialylationScience, 2006
- Pharmacokinetics of Intravenous Immunoglobulin: A Systematic ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- CD107a as a functional marker for the identification of natural killer cell activityJournal of Immunological Methods, 2004
- What does it take to make a natural killer?Nature Reviews Immunology, 2003